Review
World J Hematol
2(3):62-70.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.62
Abstract (2780)
|
Core Tip (1994)
|
Full Article (HTML) (57396)
|
Figures (1-9) (1671)
|
Full Article (PDF)-576K (2574)
|
Peer-Review Report-178K (510)
|
Answering Reviewers-107K (495)
|
Received: 04/01/2013
|
Revised: 05/14/2013
|
Accepted: 06/10/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (11)
|
Total Visits (72239)
|
Similar Articles (16)
|
Timeline of Article Publication (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
PVSG and WHO vs European Clinical, Molecular and Pathological Criteria for prefibrotic myeloproliferative neoplasms

World J Hematol
2(3):71-88.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.71
Abstract (2057)
|
Core Tip (1773)
|
Full Article (HTML) (10682)
|
Figures (1-10) (686)
|
Tables (1-6) (589)
|
Full Article (PDF)-3685K (1061)
|
Peer-Review Report-98K (501)
|
Answering Reviewers-50K (407)
|
Received: 01/11/2013
|
Accepted: 06/18/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (21205)
|
Similar Articles (5)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hematol
2(3):89-98.
Published online Aug 6, 2013.
doi: 10.5315/wjh.v2.i3.89
Abstract (2023)
|
Core Tip (1696)
|
Full Article (HTML) (8981)
|
Figures (1-6) (637)
|
Tables (1-2) (424)
|
Full Article (PDF)-1438K (826)
|
Peer-Review Report-192K (314)
|
Answering Reviewers-63K (348)
|
Received: 03/11/2013
|
Revised: 05/10/2013
|
Accepted: 06/06/2013
|
RCA
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (18793)
|
Similar Articles (34)
|
Timeline of Article Publication (4)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open